Henry S. Bienen, Director at Onconova Therapeutics, Inc. (ONTX), bought 10,000 shares at $0.38 ($4K) on 2018-05-29, disclosed to the SEC on 2018-05-31.
Open-market purchase of $4k ONTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| ONTX | BUY | 2013-08-01 | $100K | — | Filing → |